Mariaelena Pistoni

7PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersGenome structure and regulationLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 08, 2026
BET inhibition unmasks a targetable glycolytic dependency through a HIF1α stabilization and driven transcriptional program in a defined subset of triple-negative breast Cancer.

|Sep 23, 2024
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.

Ennio Nano, Francesco Reggiani, Adriana Agnese Amaro

|Sep 03, 2024
BET inhibitors (BETi) influence oxidative phosphorylation metabolism by affecting mitochondrial dynamics leading to alterations in apoptotic pathways in triple-negative breast cancer (TNBC) cells.

Teresa Rossi, Egidio Iorio, Mattea Chirico

|Sep 28, 2023
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma.

Maria Eugenia Gallo Cantafio, Roberta Torcasio, Francesca Scionti

|Jan 05, 2023
BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells.

Teresa Rossi, Raffaella Zamponi, Mattea Chirico

|Feb 06, 2021
Long Noncoding RNA NEAT1 Acts as a Molecular Switch for BRD4 Transcriptional Activity and Mediates Repression of BRD4/WDR5 Target Genes.

Mariaelena Pistoni, Teresa Rossi, Benedetta Donati

Pageof 2

Frequent Collaborators

2 joint publications

Teresa Rossi

1 joint publications

Francesca Scionti

1 joint publications

Maria Mesuraca

1 joint publications

Domenica Ronchetti